• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Scynexis Inc (NQ: SCYX )

    2.080 -0.010 (-0.48%)
    Streaming Delayed Price Updated: 2:46 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 40,861
    Open 2.070
    Bid (Size) 2.060 (5)
    Ask (Size) 2.080 (3)
    Prev. Close 2.090
    Today's Range 2.000 - 2.090
    52wk Range 1.350 - 3.870
    Shares Outstanding 37,175,665
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Dirt-Cheap Drug Developers With Blockbuster Potential
    These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent. 
    Via InvestorPlace
    7 Undervalued Biotech Stocks to Buy for Big-Time Returns
    The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. 
    Via InvestorPlace

    Performance

    YTD
    -5.88%
    -5.88%
    1 Month
    +10.05%
    +10.05%
    3 Month
    +48.04%
    +48.04%
    6 Month
    +10.05%
    +10.05%
    1 Year
    -25.98%
    -25.98%

    More News

    Read More
    Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025
    Via InvestorPlace
    3 Stocks Under $10 With Mammoth Growth Prospects
    Via InvestorPlace
    Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing?
    Via Chartmill
    SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    5 Value Stocks To Watch In The Healthcare Sector
    Via Benzinga
    SCYX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors with Losses to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    SCYX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SCYNEXIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    SCYNEXIS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    SCYX DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    SCYX IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SCYX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SCYNEXIS, Li-Cycle, and FMC and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    SCYNEXIS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    ROSEN, LEADING INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
    Via NewMediaWire
    Topics Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.